134 related articles for article (PubMed ID: 37558641)
21. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
22. Metastatic prostate cancer in an asymptomatic patient with an initial prostate-specific antigen (PSA) serum concentration of 21,380 ng/ml.
Persec Z; Persec J; Sović T; Romic Z; Bosnar Herak M; Hrgovic Z
Onkologie; 2010; 33(3):110-2. PubMed ID: 20215802
[TBL] [Abstract][Full Text] [Related]
23. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
Cornford P; Bellmunt J; Bolla M; Briers E; De Santis M; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; van der Poel HG; van der Kwast TH; Rouvière O; Wiegel T; Mottet N
Eur Urol; 2017 Apr; 71(4):630-642. PubMed ID: 27591931
[TBL] [Abstract][Full Text] [Related]
24. [Metachronous Pubic Bone Metastases from Synchronous Double Cancer with Prostate and Ascending Colon Cancers : A Case Report].
Ito H; Hishida S; Taniguchi T; Kato D; Takai M; Iinuma K; Muramatsu-Maekawa Y; Kato T; Nakane K; Mizutani K; Tsuchiya T; Takahashi T; Suzui N; Miyazaki T; Koie T
Hinyokika Kiyo; 2020 Aug; 66(8):273-277. PubMed ID: 32882125
[TBL] [Abstract][Full Text] [Related]
25. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
[TBL] [Abstract][Full Text] [Related]
26. Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.
Smith MR; Kabbinavar F; Saad F; Hussain A; Gittelman MC; Bilhartz DL; Wynne C; Murray R; Zinner NR; Schulman C; Linnartz R; Zheng M; Goessl C; Hei YJ; Small EJ; Cook R; Higano CS
J Clin Oncol; 2005 May; 23(13):2918-25. PubMed ID: 15860850
[TBL] [Abstract][Full Text] [Related]
27. Four prognostic indices in advanced prostate cancer patients, under palliative androgen deprivation treatment.
Bantis A; Zissimopoulos A; Kalaitzis C; Giannakopoulos S; Sountoulides P; Parmenopoulou V; Agelonidou E; Touloupidis S
Hell J Nucl Med; 2008; 11(1):21-5. PubMed ID: 18392222
[TBL] [Abstract][Full Text] [Related]
28. Incorporating Androgen Deprivation With Dose-Escalated External-Beam Radiotherapy for Prostate Cancer.
Dosoretz AP; Yu JB
J Clin Oncol; 2016 May; 34(15):1718-22. PubMed ID: 27001587
[TBL] [Abstract][Full Text] [Related]
29. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial.
Boevé LMS; Hulshof MCCM; Vis AN; Zwinderman AH; Twisk JWR; Witjes WPJ; Delaere KPJ; Moorselaar RJAV; Verhagen PCMS; van Andel G
Eur Urol; 2019 Mar; 75(3):410-418. PubMed ID: 30266309
[TBL] [Abstract][Full Text] [Related]
30. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan.
Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I
Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940
[TBL] [Abstract][Full Text] [Related]
31. Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.
Heidenreich A; Fossati N; Pfister D; Suardi N; Montorsi F; Shariat S; Grubmüller B; Gandaglia G; Briganti A; Karnes RJ
Eur Urol Oncol; 2018 May; 1(1):46-53. PubMed ID: 31100228
[TBL] [Abstract][Full Text] [Related]
32. Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.
Miyamoto S; Ito K; Miyakubo M; Suzuki R; Yamamoto T; Suzuki K; Suzuki K; Yamanaka H
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):75-86. PubMed ID: 21986985
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer presenting with normal serum PSA levels and boney metastases treated with zoledronic acid.
Mystakidou K; Katsouda E; Parpa E; Vlahos L
J Pain Palliat Care Pharmacother; 2005; 19(3):41-5. PubMed ID: 16219610
[TBL] [Abstract][Full Text] [Related]
34. Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?
Vargas HA; Martin-Malburet AG; Takeda T; Corradi RB; Eastham J; Wibmer A; Sala E; Zelefsky MJ; Weber WA; Hricak H
Urol Oncol; 2016 Nov; 34(11):482.e5-482.e10. PubMed ID: 27346339
[TBL] [Abstract][Full Text] [Related]
35. [Successful complete androgen blockade (CAB) therapy for prostatic cancer detected from multiple lung metastases: a case report].
Tokumitsu M; Inada F; Kitahara K; Kawakami N; Masui N; Ishida H; Ishida H; Saga Y; Hashimoto H; Yachiku S
Hinyokika Kiyo; 2001 Jan; 47(1):59-62. PubMed ID: 11235226
[TBL] [Abstract][Full Text] [Related]
36. Lymph node-positive prostate cancer: evaluation of the results of the combination of androgen deprivation therapy and radiation therapy.
Buskirk SJ; Pisansky TM; Atkinson EJ; Schild SE; O'Brien PC; Wolfe JT; Zincke H
Mayo Clin Proc; 2001 Jul; 76(7):702-6. PubMed ID: 11444402
[TBL] [Abstract][Full Text] [Related]
37. MRI of the skeleton in prostate cancer staging.
Rydh A; Lundblad M; Ahlström KR; Tavelin B; Stattin P
Scand J Urol Nephrol; 2003; 37(3):222-5. PubMed ID: 12775281
[TBL] [Abstract][Full Text] [Related]
38. Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction.
Flaig TW; Plets M; Hussain MHA; Agarwal N; Mitsiades N; Deshpande HA; Vaishampayan UN; Thompson IM
JAMA Oncol; 2017 Nov; 3(11):e170231. PubMed ID: 28358937
[TBL] [Abstract][Full Text] [Related]
39. Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase.
Xie W; Nakabayashi M; Regan MM; Oh WK
Cancer; 2007 Dec; 110(12):2709-15. PubMed ID: 17960608
[TBL] [Abstract][Full Text] [Related]
40. [A case of prostate cancer associated with osteolytic bone metastases].
Migita T; Maeda K; Ogata N
Hinyokika Kiyo; 1999 May; 45(5):371-4. PubMed ID: 10410324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
